Kathleen Wills

6/1/2022  /  Appeals , Appointments Clause , Arthrex Inc v Smith & Nephew Inc , Claim Construction , Clear and Convincing Evidence , Constitutional Challenges , Damages , Director of the USPTO , Evidence , Experimental Use Exception , Expert Testimony , Federal Vacancies Reform Act , Inter Partes Review (IPR) Proceeding , Inventions , Inventors , Motivation to Combine , Obviousness , On-Sale Bar , Patent Applications , Patent Infringement , Patent Litigation , Patent Trial and Appeal Board , Patents , Petition For Rehearing , Post-Grant Review , Prior Art , Remand , Section 102 , Separation of Powers , Substantial Evidence Standard , USPTO , Vacated

3/30/2022  /  Artificial Intelligence , Authorship , Biopharmaceutical , Copyright , Copyright Applications , Copyright Office , Copyright Registration , FDA Approval , Intellectual Property Protection , Marijuana Related Businesses , Medical Marijuana , Medical Research , New Legislation , Patent Applications , Patent Registration , Patents , Pharmaceutical Patents , Photographs , The Copyright Act

3/1/2022  /  Evidence , Federal Rules of Evidence , Intellectual Property Protection , Inter Partes Review (IPR) Proceeding , Patent Prosecution , Patent Trial and Appeal Board , Patents , Prior Art , Remand , Reversal

2/25/2022  /  Appropriation , Cannabis Products , Cannabis-Related Businesses (CRBs) , Claim Construction , Dilution , Fair Use , First Amendment , Intellectual Property Protection , Non-Fungible Tokens (NFTs) , Patent Infringement , Patent Litigation , Patents , Right To Appeal , Trademark Infringement , Trademark Litigation , Trademarks , Unfair Competition

2/9/2022  /  § 314(d) , 35 U.S.C. §315(e)(1) , Absolute Intervening Rights Doctrine , Abuse of Discretion , Administrative Patent Judges , Administrative Procedure Act , America Invents Act , Appeals , Appointments Clause , Arbitrary and Capricious , Article of Manufacture , Assignor Estoppel , Burden of Proof , Claim Construction , Collateral Estoppel , Commercial Success , Confidential Information , Constitutional Challenges , Demand Letter , Denial of Institution , Design Patent , Director of the USPTO , Dismissals , Doctrine of Prosecution Disclaimer , Due Process , Equitable Estoppel , Estoppel , Evidence , Ex Partes Reexamination , Executive Branch , Executive Powers , Federal Rules of Evidence , Final Written Decisions , Forum Selection , FRCP 52(c) , GATT , Inferior Officers , Intellectual Property Litigation , Intellectual Property Protection , Inter Partes Reexamination , Inter Partes Review (IPR) Proceeding , International Trade Commission (ITC) , Intervening Acts , Inventions , Issue Preclusion , Judicial Review , Lack of Authority , Lack of Jurisdiction , Likelihood of Success , Minerva Surgical Inc. v Hologic Inc. , Motion for Summary Judgment , Motivation to Combine , Nexus , Non-Disclosure Agreement , Nonobvious , Obviousness , Ornamental Design , Parallel Proceedings , Patent Applications , Patent Filings , Patent Infringement , Patent Litigation , Patent Prosecution , Patent Trial and Appeal Board , Patent Validity , Patents , Petition for Writ of Certiorari , Pharmaceutical Patents , Post-Grant Review , Pre-GATT , Preliminary Injunctions , Principle Officers , Printed Publications , Prior Art , Real Party in Interest , Remand , Reversal , Rule 36 , Scope of Review , SCOTUS , Section 325(d) , Sua Sponte , Substantial Evidence , Totality of Evidence , United States v Arthrex Inc , USPTO , Vacated , Writ of Mandamus

2/2/2022  /  Claim Construction , Expert Testimony , Expert Witness , Intellectual Property Litigation , Intellectual Property Protection , Patent Infringement , Patent Litigation , Patent Prosecution , Patent Validity , Patents , Pharmaceutical Patents , Written Descriptions

2/1/2022  /  Abuse of Discretion , Administrative Law Judge (ALJ) , Claim Construction , Doctrine of Equivalents , Expert Testimony , Expert Witness , Intellectual Property Litigation , Intellectual Property Protection , International Trade Commission (ITC) , Patent Infringement , Patent Litigation , Patent Trial and Appeal Board , Patent Validity , Patents , Pharmaceutical Patents , Precedential Opinion , USPTO , Written Descriptions

12/1/2021  /  Cannabis Products , Cease and Desist Orders , Design Patent , Entertainment Industry , Exclusion Orders , Imports , Intellectual Property Protection , International Trade Commission (ITC) , Movies , Non-Fungible Tokens (NFTs) , Patent Infringement , Patents , Quentin Tarantino , Trademark Application , Trademark Registration , Trademarks , Utility Patents , Vaping

8/30/2021  /  Brand , Cannabis Products , Cannabis-Related Businesses (CRBs) , Domain Name Registration , Domain Names , gTLD , ICANN , Intellectual Property Litigation , Intellectual Property Protection , Intent-to-Use , Monster Energy Drinks , Patent Infringement , Patent Litigation , Patents , Sunrise Periods , Trade Dress , Trademark Application , Trademark Cancellation , Trademark Electronic Application System (TEAS) , Trademark Infringement , Trademark Litigation , Trademark Modernization Act (TMA) , Trademark Opposition Proceedings , Trademark Registration , Trademark Trial and Appeal Board , Trademarks , USPTO